Matt O'Brien

Stock Analyst at Piper Sandler

(2.19)
# 2,902
Out of 5,041 analysts
187
Total ratings
42.58%
Success rate
-4.94%
Average return

Stocks Rated by Matt O'Brien

Integer Holdings
Oct 24, 2025
Maintains: Overweight
Price Target: $155$82
Current: $72.91
Upside: +12.47%
OrthoPediatrics
Oct 10, 2025
Maintains: Overweight
Price Target: $30$22
Current: $17.03
Upside: +29.18%
Shoulder Innovations
Aug 25, 2025
Initiates: Overweight
Price Target: $18
Current: $12.30
Upside: +46.34%
Carlsmed
Aug 18, 2025
Initiates: Overweight
Price Target: $18
Current: $13.46
Upside: +33.73%
PROCEPT BioRobotics
Aug 7, 2025
Maintains: Overweight
Price Target: $80$55
Current: $34.99
Upside: +57.19%
Tandem Diabetes Care
Aug 7, 2025
Downgrades: Neutral
Price Target: $30$14
Current: $14.95
Upside: -6.35%
DexCom
Jul 31, 2025
Maintains: Overweight
Price Target: $90$100
Current: $70.33
Upside: +42.19%
CONMED
Jul 31, 2025
Maintains: Overweight
Price Target: $80$68
Current: $47.76
Upside: +42.38%
TransMedics Group
Jun 4, 2025
Reiterates: Overweight
Price Target: $125$145
Current: $130.52
Upside: +11.09%
Globus Medical
May 9, 2025
Maintains: Overweight
Price Target: $100$80
Current: $62.29
Upside: +28.43%
Maintains: Overweight
Price Target: $20$12
Current: $10.45
Upside: +14.83%
Reiterates: Overweight
Price Target: $13$15
Current: $16.11
Upside: -6.89%
Maintains: Overweight
Price Target: $180$165
Current: $74.67
Upside: +120.97%
Initiates: Overweight
Price Target: $27
Current: $26.00
Upside: +3.85%
Downgrades: Neutral
Price Target: $5$2
Current: $1.47
Upside: +35.78%
Maintains: Neutral
Price Target: $5.5$3.5
Current: $5.28
Upside: -33.65%
Downgrades: Neutral
Price Target: $255$140
Current: $131.91
Upside: +6.13%
Initiates: Overweight
Price Target: $26
Current: $20.97
Upside: +23.99%
Maintains: Overweight
Price Target: $285$310
Current: $320.91
Upside: -3.40%
Reiterates: Overweight
Price Target: $250$330
Current: $252.99
Upside: +30.44%
Maintains: Overweight
Price Target: $40$50
Current: $37.54
Upside: +33.19%
Maintains: Neutral
Price Target: $40$16
Current: $26.27
Upside: -39.09%
Maintains: Overweight
Price Target: $95$115
Current: $101.11
Upside: +13.74%
Reiterates: Neutral
Price Target: $9$12
Current: $3.97
Upside: +202.27%
Reiterates: Overweight
Price Target: $380$420
Current: $381.79
Upside: +10.01%
Maintains: Neutral
Price Target: $85$90
Current: $93.67
Upside: -3.92%
Initiates: Overweight
Price Target: $25
Current: $15.49
Upside: +61.39%
Maintains: Neutral
Price Target: $3.5$3
Current: $1.71
Upside: +75.44%
Maintains: Overweight
Price Target: $4$4.5
Current: $3.21
Upside: +40.19%
Upgrades: Overweight
Price Target: n/a
Current: $103.03
Upside: -
Initiates: Overweight
Price Target: $15
Current: $3.96
Upside: +278.79%
Maintains: Overweight
Price Target: $93$109
Current: $73.51
Upside: +47.94%
Downgrades: Neutral
Price Target: $25$18
Current: $1.40
Upside: +1,198.57%
Downgrades: Neutral
Price Target: $100$80
Current: $23.02
Upside: +247.52%
Initiates: Overweight
Price Target: $12
Current: $4.23
Upside: +183.69%